MayTech Global Investments Trims Its $59 Million MercadoLibre Position: Should Investors Take Some Profits Too?

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

According to a filing with the Securities and Exchange Commission dated Nov. 13, 2025, Wolf Hill Capital Management reduced ...

Rule of 30 to 40 Trajectory -- Management expects the combined company could approach the sum of revenue growth rate plus ...

In Jim Cramer's "Stop Trading" segment on CNBC's Squawk on the Street program, the famous stock picker mentioned Amgen ...

Florida Expansion -- Delegated capitation agreement with Elevance Health expanded in Q4 to include additional Medicare ...

Consumer goods conglomerate Spectrum Brands ( SPB +9.79%) had a mixed fiscal fourth quarter of 2025 as detailed in the ...

Ballast Asset Management trimmed its Solaris Energy Infrastructure (SEI) position in Q3, locking in some gains after the ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

Picky market players weren't impressed by the company's twin beats in its latest reported quarter.

And except as required by law, STRATA Skin Sciences disclaims any obligation to publicly update or revise any information to ...